Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Navari, Rudolph M
Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. [electronic resource] - Expert review of anticancer therapy Oct 2004 - 715-24 p. digital
Publication Type: Journal Article; Review
1744-8328
10.1586/14737140.4.5.715 doi
Adolescent
Adult
Aged
Antiemetics--therapeutic use
Antineoplastic Agents--adverse effects
Aprepitant
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Morpholines--therapeutic use
Nausea--chemically induced
Risk Factors
Vomiting--chemically induced
Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. [electronic resource] - Expert review of anticancer therapy Oct 2004 - 715-24 p. digital
Publication Type: Journal Article; Review
1744-8328
10.1586/14737140.4.5.715 doi
Adolescent
Adult
Aged
Antiemetics--therapeutic use
Antineoplastic Agents--adverse effects
Aprepitant
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Morpholines--therapeutic use
Nausea--chemically induced
Risk Factors
Vomiting--chemically induced